tDCS for Dual-task Performance in Patients With PD
Transcranial Direct Current Stimulation to Improve Dual-task Performance in Idiopathic Parkinson's Disease: A Prospective, Single-center, Double-blind, Explorative Clinical Trial
1 other identifier
interventional
24
1 country
1
Brief Summary
The purpose of this study is to investigate the optimal stimulation location of transcranial direct current stimulation to improve the dual-task performance in patients with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Nov 2020
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2020
CompletedFirst Posted
Study publicly available on registry
August 7, 2020
CompletedStudy Start
First participant enrolled
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 13, 2024
CompletedFebruary 20, 2024
February 1, 2024
3.3 years
August 5, 2020
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive dual-task interference (%) in Timed-up & go test
Percentage of dual-task interference calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]
Immediately after a 20-minute tDCS session
Physical dual-task interference (%) in Timed-up & go test
Percentage of dual-task interference calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]
Immediately after a 20-minute tDCS session
Secondary Outcomes (6)
Timed-up & go test (sec): single task
Immediately after a 20-minute tDCS session
Timed-up & go test (sec): cognitive dual-task
Immediately after a 20-minute tDCS session
Timed-up & go test (sec): physical dual-task
Immediately after a 20-minute tDCS session
Stroop test
Immediately after a 20-minute tDCS session
Trail making test
Immediately after a 20-minute tDCS session
- +1 more secondary outcomes
Study Arms (4)
Primary motor cortex
EXPERIMENTALThe anodic electrode is positioned in the primary motor cortex (Cz) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.
Left dorsolateral prefrontal cortex
EXPERIMENTALThe anodic electrode is positioned in the left dorsolateral prefrontal cortex (F3) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.
Ventromedial prefrontal cortex
EXPERIMENTALThe anodic electrode is positioned in the ventromedial prefrontal cortex (Fpz) and the cathode electrode on the left dorsolateral prefrontal cortex (F4). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.
Sham stimulation
SHAM COMPARATORThe anodic electrode is positioned in the primary motor cortex (Cz) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA during first 30 seconds, decreases to 0 mA over 30 seconds, and then stops supplying for 19 minutes.
Interventions
tDCS was applied for 20 minutes through two saline-soaked sponge electrodes (diameter 6cm) using the YMS-201B (Ybrain Inc, South Korea).
Eligibility Criteria
You may qualify if:
- Clinically diagnosed as idiopathic Parkinson's disease
- modified Hoehn \& Yahr stage 2, 2.5, or 3
You may not qualify if:
- History of seizure
- Metallic implants, such as cardiac pacemaker or an artificial cochlea
- Patients with inflammation, burns, or wounds in the stimulation area
- Parkinson's disease dementia; cut-off is \< 7 of Korean-Montreal Cognitive Assessment for illiterate patients, \< 13 for those educated for 0.5-3 years, \< 16 for 4-6 years of education, \< 19 for 7-9 years of education, and \< 20 for 10 or more years of education.
- Severe dyskinesia or severe on-off phenomenon
- Plan to adjust medication at the time of screening
- Sensory abnormalities of the lower extremities, other neurological or orthopedic disease affecting lower extremities, or severe cardiovascular diseases
- Vestibular disease or paroxysmal vertigo
- Pregnant or lactating patients
- Other comorbidities that make it difficult to participate in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, 03080, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Han Gil Seo, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 5, 2020
First Posted
August 7, 2020
Study Start
November 5, 2020
Primary Completion
February 13, 2024
Study Completion
February 13, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02